Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 25, 2024 08:05 ET | Source: Shareholder Capital LLC

Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals

Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals
March 17, 2021 13:56 ET | Source: Barr Law Group

SHAREHOLDER ALERT: Barr Law Group Investigating VNDA, VLDR, RIDE, and ABT; Shareholders are Encouraged to Contact the Firm

SAN DIEGO, March 17, 2021 (GLOBE NEWSWIRE) -- National law firm Barr Law Group is investigating the actions of the officers and board of directors of Vanda Pharmaceuticals Inc., Velodyne Lidar,...
April 25, 2019 10:00 ET | Source: Schall Law

FRIDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vanda Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, April 25, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Vanda Pharmaceuticals Inc....
April 17, 2019 16:11 ET | Source: Block & Leviton LLP

A Securities Class Action Has Been Filed Against Vanda; Block & Leviton LLP Encourages Shareholders to Contact the Firm

BOSTON, April 17, 2019 (GLOBE NEWSWIRE) -- Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, informs investors that there has been a class...
March 28, 2019 09:30 ET | Source: Hagens Berman Sobol Shapiro LLP

Hagens Berman Reminds Vanda Pharmaceuticals (NASDAQ: VNDA) Investors of the April 26, 2019 Lead Plaintiff Deadline and Unsealed Government Lawsuit

SAN FRANCISCO, March 28, 2019 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP reminds investors in Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) of the April 26, 2019 Lead Plaintiff deadline in the...
March 26, 2019 15:38 ET | Source: Block & Leviton LLP

Block & Leviton LLP Reminds Shareholders of Important Deadlines: AMRN, ASTE, INGN, VNDA

BOSTON, March 26, 2019 (GLOBE NEWSWIRE) -- Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, reminds investors of the important deadlines...
March 12, 2019 16:44 ET | Source: Zhang Investor Law P.C.

VNDA ALERT: Zhang Investor Law Announces the Filing of a Securities Class Action Lawsuit Against Vanda Pharmaceuticals Inc. – VNDA

NEW YORK, March 12, 2019 (GLOBE NEWSWIRE) -- Zhang Investor Law announces the filing of a class action lawsuit on behalf of shareholders who bought shares of Vanda Pharmaceuticals Inc. (NASDAQ:...
March 05, 2019 14:52 ET | Source: Schall Law

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vanda Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, March 05, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Vanda Pharmaceuticals Inc....
February 14, 2019 15:00 ET | Source: Schall Law

ONGOING INVESTIGATION: The Schall Law Firm Announces it is Investigating Claims Against Vanda Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, Feb. 14, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Vanda...
February 11, 2019 10:49 ET | Source: Block & Leviton LLP

Vanda Pharmaceuticals Inc. Investigated by Block & Leviton LLP For Violations of Federal Securities Laws

BOSTON, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, is investigating whether Vanda Pharmaceuticals...